ニュートライングレディエンツ-アジア (NutraIngredients-Asia)日本語版ニュースレター 発行
健康、栄養とサプリメント業界に関するニュースと見識を満載した日本語と英語で読めるNutraIngredients-Asia.com 日本向けニュースレター 第一号です。
健康、栄養とサプリメント業界に関するニュースと見識を満載した日本語と英語で読めるNutraIngredients-Asia.com 日本向けニュースレター 第一号です。
The global microbiome market is forecast to nearly triple in size to €0.44bn ($0.5bn) by 2022, according to a new report, which pinpointed France, Israel and the US as market leaders.
An expert panel convened by the International Scientific Association for Probiotics and Prebiotics (ISAPP) has updated the definition of “prebiotics” to take into account advances in sequencing technology and the expansion in the use of the ingredients...
Quatrefolic, the metabolically active form of folate, has been granted approval as a certified food additive by the South Korean Ministry of Food and Drug Safety (MFDS).
Cardax, a Hawaii-based developer of synthetic astaxanthin, announced that the company’s proprietary carotenoid compound has been chosen for a National Institute on Aging test program.
The recent briefing for members of the Dietary Supplement Caucus featured an appearance by a world-class athlete speaking in favor of supplementation.
Decreased plasma selenium levels in children with persistent diarrhoea could be caused by protein loss and faecal fungi, according to an Indonesian study.
A weight loss supplement has been branded "a serious health risk" after officials in Australia found it contained the prescription-only medication sibutramine.
NutraIngredients-Asia.com has launched a Japan newsletter to provide news and insights about the nutrition, health and dietary supplements industry with content produced in both Japanese and English.
Researchers in Singapore who have created a probiotic beer are on the lookout for industry partners to launch the product to consumers.
Biofortification alone is not enough to enhance bread with optimum iron and zinc levels to fight deficiencies, a study says as it cites other production methods that should factor in its creation.
A higher ratio of omega-3 to omega-6 enzymes is linked to better survival rate in bowel cancer according to a recent study published in the British Journal of Cancer.
Regulatory hurdles must be kept in mind when designing studies to support products. This is especially true in research on probiotics, an expert says.